Cancer Targeted Technology
Woodinville
About Cancer Targeted Technology
Cancer Targeted Technology is a biotechnology company ommercializing innovative small molecules that bind pivotal enzyme targets in cancer. CTT has rationally designed and patented a targeting scaffold that recognizes the molecular target, Prostate-Specific Membrane Antigen (PSMA), with unparalleled binding characteristics, making it stand out from its competitors
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.4M
- Last round: Grant (Nov 2024)
- Website: cancertargetedtechnology.com
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cancer-targeted-technology-85659 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.